Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009, Article ID 308596, 9 pages
http://dx.doi.org/10.1155/2009/308596
Research Article

IL-1β Suppresses the Formation of Osteoclasts by Increasing OPG Production via an Autocrine Mechanism Involving Celecoxib-Related Prostaglandins in Chondrocytes

1Nihon University Graduate School of Dentistry, Tokyo 101-8310, Japan
2Department of Fixed Prosthodontics, Nihon University School of Dentistry, 1-8-13, Kanda Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan
3Division of Advanced Dental Treatment, Dental Research Center, Nihon University School of Dentistry, Tokyo 101-8310, Japan
4Department of Oral Health Sciences, Nihon University School of Dentistry, Tokyo 101-8310, Japan
5Department of Biochemistry, Nihon University School of Dentistry, Tokyo 101-8310, Japan
6Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry, Tokyo 101-8310, Japan

Received 25 June 2009; Revised 28 August 2009; Accepted 1 December 2009

Academic Editor: Muzamil Ahmad

Copyright © 2009 Yusuke Watanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Bezerra, J. F. Carvalho, A. S. Prokopowitsch, and R. M. R. Pereira, “RANK, RANKL and osteoprotegerin in arthritic bone loss,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 2, pp. 161–170, 2005. View at Google Scholar · View at Scopus
  2. N. Tanabe, M. Maeno, N. Suzuki et al., “IL-1a stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts,” Life Sciences, vol. 77, no. 6, pp. 615–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. L. Lacey, E. Timms, H.-L. Tan et al., “Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation,” Cell, vol. 93, no. 2, pp. 165–176, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Komuro, T. Olee, K. Kühn et al., “The osteoprotegerin/receptor activator of nuclear factor ?B/receptor activator of nuclear factor ?B ligand system in cartilage,” Arthritis and Rheumatism, vol. 44, no. 12, pp. 2768–2776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sakata, H. Shiba, H. Komatsuzawa et al., “Osteoprotegerin levels increased by interleukin-1ß in human periodontal ligament cells are suppressed through prostaglandin E2 synthesized de novo,” Cytokine, vol. 18, no. 3, pp. 133–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kishimoto, R. Kitazawa, M. Kurosaka, S. Maeda, and S. Kitazawa, “Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage,” Histochemistry and Cell Biology, vol. 125, no. 5, pp. 593–602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. E. Chin, G. E. Winterrowd, R. F. Krzesicki, and M. E. Sanders, “Role of cytokines in inflammatory synovitis: the coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts,” Arthritis and Rheumatism, vol. 33, no. 12, pp. 1776–1786, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Strand and A. F. Kavanaugh, “The role of interleukin-1 in bone resorption in rheumatoid arthritis,” Rheumatology, vol. 43, supplement 3, pp. iii10–iii16, 2004. View at Google Scholar · View at Scopus
  9. T. Horiuchi, T. Yoshida, Y. Koshihara et al., “The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis,” Endocrine Journal, vol. 46, no. 5, pp. 643–649, 1999. View at Google Scholar · View at Scopus
  10. Y. Tanaka, S. Nakayamada, and Y. Okada, “Osteoblasts and osteoclasts in bone remodeling and inflammation,” Current Drug Targets: Inflammation & Allergy, vol. 4, no. 3, pp. 325–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Foged, “Temporomandibular arthrosis,” The Lancet, vol. 2, no. 6592, pp. 1209–1211, 1949. View at Google Scholar · View at Scopus
  12. S. R. Frenkel and P. E. Di Cesare, “Degradation and repair of articular cartilage,” Frontiers in Bioscience, vol. 4, pp. D671–D685, 1999. View at Google Scholar · View at Scopus
  13. A. R. Poole, “An introduction to the pathophysiology of osteoarthritis,” Frontiers in Bioscience, vol. 4, pp. D662–D670, 1999. View at Google Scholar · View at Scopus
  14. H. Mori, K. Nishida, T. Ozaki, H. Inoue, and T. Nakanishi, “Isolation of a mRNA preferentially expressed in synoviocytes from rheumatoid arthritis that is identical with lumican, which encodes a collagen binding extracellular matrix protein,” Journal of Hard Tissue Biology, vol. 17, no. 3, pp. 125–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Alstergren, C. Benavente, and S. Kopp, “Interleukin-1β, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 10, pp. 1171–1178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Takahashi, T. Kondoh, M. Fukuda, Y. Yamazaki, T. Toyosaki, and R. Suzuki, “Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 85, no. 2, pp. 135–141, 1998. View at Google Scholar · View at Scopus
  17. P. Alstergren, M. Ernberg, M. Kvarnström, and S. Kopp, “Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite,” Journal of Oral and Maxillofacial Surgery, vol. 56, no. 9, pp. 1059–1065, 1998. View at Google Scholar · View at Scopus
  18. E. Kubota, H. Imamura, T. Kubota, T. Shibata, and K.-I. Murakami, “Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint,” Journal of Oral and Maxillofacial Surgery, vol. 55, no. 1, pp. 20–27, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Aida, M. Maeno, E. Ito-Kato, N. Suzuki, H. Shiratsuchi, and H. Matsumura, “Effect of IL-1α on the expression of cartilage matrix proteins in human chondrosarcoma cell line OUMS-27,” Life Sciences, vol. 75, no. 26, pp. 3173–3184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Aida, M. Maeno, N. Suzuki, H. Shiratsuchi, M. Motohashi, and H. Matsumura, “The effect of IL-1β on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes,” Life Sciences, vol. 77, no. 25, pp. 3210–3221, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Aida, M. Maeno, N. Suzuki et al., “The effect of IL-1ß on the expression of inflammatory cytokines and their receptors in human chondrocytes,” Life Sciences, vol. 79, no. 8, pp. 764–771, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Namba, Y. Aida, N. Suzuki et al., “Effects of IL-6 and soluble IL-6 receptor on the expression of cartilage matrix proteins in human chondrocytes,” Connective Tissue Research, vol. 48, no. 5, pp. 263–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Watanabe, A. Namba, K. Honda et al., “IL-1ß stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2,” Connective Tissue Research, vol. 50, no. 3, pp. 186–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Yoshino, A. Kimoto, S. Kobayashi et al., “Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor,” Arzneimittel-Forschung, vol. 55, no. 7, pp. 394–402, 2005. View at Google Scholar · View at Scopus
  25. C. Itthipanichpong, S. Chompootaweep, S. Wittayalertpanya et al., “Clinical pharmacokinetic of celecoxib in healthy Thai volunteers,” Journal of the Medical Association of Thailand, vol. 88, no. 5, pp. 632–638, 2005. View at Google Scholar · View at Scopus
  26. S. Gillis, M. M. Ferm, W. Ou, and K. A. Smith, “T cell growth factor: parameters of production and a quantitative microassay for activity,” Journal of Immunology, vol. 120, no. 6, pp. 2027–2032, 1978. View at Google Scholar · View at Scopus
  27. K. Fujisaki, N. Tanabe, N. Suzuki et al., “Receptor activator of NF-?B ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells,” Life Sciences, vol. 80, no. 14, pp. 1311–1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Burstone, “Histochemical demonstration of acid phosphatases with naphthol AS-phosphates,” Journal of the National Cancer Institute, vol. 20, no. 3, pp. 601–615, 1958. View at Google Scholar
  29. C. Shinoda and S. Takaku, “Lnterleukin-1 β, interleukin-6, and tissue inhibitor of metalloproteinase-l in the synovial fluid of the temporomandibular joint with respect to cartilage destruction,” Oral Diseases, vol. 6, no. 6, pp. 383–390, 2000. View at Google Scholar · View at Scopus
  30. N. A. Sandler, M. J. Buckley, J. E. Cillo, and T. W. Braun, “Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements,” Journal of Oral and Maxillofacial Surgery, vol. 56, no. 5, pp. 534–543, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Alstergren, S. Kopp, and E. Theodorsson, “Synovial fluid sampling from the temporomandibular joint: sample quality criteria and levels of interleukin-1β and serotonin,” Acta Odontologica Scandinavica, vol. 57, no. 1, pp. 16–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. I. K. Campbell, G. Ianches, and J. A. Hamilton, “Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor α,” Biochimica et Biophysica Acta, vol. 1182, no. 1, pp. 57–63, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Deschner, E. Wypasek, M. Ferretti, B. Rath, M. A. Anghelina, and S. Agarwal, “Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscus,” Journal of Biomechanics, vol. 39, no. 10, pp. 1796–1803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Quintero, H. Riera, G. Colantuoni et al., “Granulocyte-macrophage colony stimulating factor is anabolic and interleukin-1ß is catabolic for rat articular chondrocytes,” Cytokine, vol. 44, no. 3, pp. 366–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Saidenberg-Kermanac'h, M. Cohen-Solal, N. Bessis, M.-C. De Vernejoul, and M.-C. Boissier, “Role for osteoprotegerin in rheumatoid inflammation,” Joint Bone Spine, vol. 71, no. 1, pp. 9–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Coon, A. Gulati, C. Cowan, and J. He, “The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption,” Journal of Endodontics, vol. 33, no. 4, pp. 432–436, 2007. View at Publisher · View at Google Scholar · View at Scopus